In order to receive credit for this activity, you must read the front matter, view the activity, achieve a passing of at least 100% on this post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.

Question Title

* 1. What are your specialty & credentials?

Question Title

* 2. What is your community of practice?

Question Title

* 3. What was the most common ≥ grade 3 TRAE associated with enfortumab-vedotin and pembrolizumab in EV-302/ KEYNOTE-A39?

Question Title

* 4. In JAVELIN Bladder 100 trial, what was the OS rate at 1 year for patients treated with avelumab maintenance therapy?

Question Title

* 5. A 72-year-old man with mUC is found to have progressive disease on restaging scans 10 months after receiving 1L gemcitabine and cisplatin. Which of the following is the preferred NCCN 2L treatment for this patient?

Question Title

* 6. In THOR, cohort 1, what was the mPFS for patients treated with erdafitinib?

EVALUATION FORM

Question Title

* 7. Upon completion of this activity, I am able to:

  Strongly agree Agree Disagree Strongly disagree
DESCRIBE efficacy data regarding ICIs and other approved drug classes, including the use of maintenance  therapy in mUC.
SELECT appropriate treatment based on the latest recommendations from the National Comprehensive Cancer  Network’s preferred treatment regimens for mUC.

Question Title

* 8. Please indicate the extent of your agreement with the following statements: 

  Strongly agree Agree Disagree Strongly disagree
The faculty for this activity were effective

Question Title

* 9. Overall, was this activity fair, balanced and free from commercial bias?

Question Title

* 10. If no, please explain:

Question Title

* 11. Of the patients with bladder cancer you will see in the next month, about how many will benefit from the information you learned today?

Question Title

* 12. Based on what I learned today, I will improve my practice by incorporating the following (check all that apply):

Question Title

* 13. Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):

Question Title

* 14. For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*

Question Title

* 15. I certify that I have participated in the continuing education activity entitled, "What Now, What Next? Appropriate Management for mUC | How I Practice: Treatment Landscape for mUC" and claim 0.5 AMA PRA Category 1 CreditTM.

Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate.

For additional information about the accreditation of this activity, please visit https://www.partnersed.com

T